GLRE Stock News 32.79 05/13/2014 05:50:10 Greenlight Capital

New Post Public Reply Private Reply Replies (0) Message Board

May 13, 2014 at 6:50 AM

Greenlight Capital Re (GLRE) 32.79 $GLRE

athenahealth Crumbles on Einhorn's Short Call - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 08, 3:20PM CDT
Shares of athenahealth (ATHN) sunk nearly 15% to date after Einhorn's description of it as a "bubble stock."

Insurance Stocks Running Out of Steam - Industry Outlook
Kalyan Nandy - Zacks Investment Research - Thu May 08, 4:17AM CDT
Insurance Stocks Running Out of Steam - Industry Outlook

Insurance Stocks Running Out of Steam - Zacks Analyst Interviews
Kalyan Nandy - Zacks Investment Research - Thu May 08, 4:17AM CDT
Insurance Stocks Running Out of Steam - Zacks Analyst Interviews

Greenlight Re Announces First Quarter 2014 Financial Results
GlobeNewswire - Mon May 05, 3:41PM CDT
Greenlight Capital Re, Ltd. (Nasdaq:GLRE) today announced financial results for the first quarter ended March 31, 2014. Greenlight Re reported net loss of $8.9 million for the first quarter of 2014 compared to net income of $56.7 million for the same period in 2013. The net loss per share was $0.24 compared to fully diluted net income per share of $1.52 for the same period in 2013.

Greenlight Capital Re to Release First Quarter 2014 Results
GlobeNewswire - Wed Apr 30, 7:00AM CDT
Greenlight Capital Re, Ltd. (Nasdaq:GLRE), a specialist property and casualty reinsurer based in the Cayman Islands and Ireland, today announced that it expects to release financial results for the first quarter ended March 31, 2014 after the market closes on Monday, May 5, 2014. A live conference call to discuss the financial results will be held on Tuesday, May 6, 2014 at 9:00 a.m. Eastern time.

Global Indemnity (GBLI) Surges: Why It Still Has Room to Run? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 7:39AM CDT
Global Indemnity has been witnessing a significant price rise in the past month with a positive momentum in the earnings estimate front

Greenlight Capital Re Earnings Hindsight: Down 1.4% in Last 20 Days (GLRE)
Comtex SmarTrend(R) - Mon Mar 10, 7:37AM CDT
Two weeks ago on February 18th, 2014 Greenlight Capital Re (NASDAQ:GLRE) reported earnings and analysts, on average, expected earnings of $2.42 on sales of $221.0 million. Greenlight Capital Re actually reported earnings of $2.22 per share on sales of $224.0 million, missing EPS estimates by $0.20 and beating revenue estimates by $3.0 million. Shares of Greenlight Capital Re have slipped from $32.37 to $31.93, representing a loss of 1.4%, since the company reported earnings 20 days ago.

Infinity Property and Casualty Earnings Miss Ests, Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 11:40AM CST
Infinity Property and Casualty reported fourth-quarter 2013 operating earnings of 70 cents a share, missing the Zacks Consensus Estimate of 75 cents by 6.7%.

Global Indemnity (GBLI) in Focus: Stock Moves 8.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 8:21AM CST
Global Indemnity plc (GBLI) was a big mover last session, as the company saw its shares rise by over 8% on the day.

RenaissanceRe Hikes Quarterly Dividend - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 3:00PM CST
The board of directors of RenaissanceRe approved a 3.6% increase in its quarterly cash dividend and the company will now pay a dividend of 29 cents per share.

EMC Insurance Beats on Q4 Earnings, Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 11:50AM CST
EMC Insurance reported fourth-quarter operating net earnings of 95 cents a share, surpassing the Zacks Consensus Estimate of 87 cents a share by 9.2%

Maiden Beats on Q4 Earnings, Misses Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 12:00PM CST
Maiden Holdings reported record fourth-quarter 2013 operating net earnings of 30 cents a share, beating the Zacks Consensus Estimate of 28 cents by 7.1%.

Greenlight Misses on Q4 Earnings, Grows Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 10:00AM CST
Greenlight Capital Re, Ltd. reported fourth-quarter 2013 net earnings per share of $2.22

Greenlight Re Announces Fourth Quarter and Year End 2013 Financial Results
GlobeNewswire - Tue Feb 18, 3:01PM CST
Greenlight Capital Re, Ltd. (Nasdaq:GLRE) today announced financial results for the fourth quarter and year ended December 31, 2013. Greenlight Re reported net income of $83.9 million for the fourth quarter 2013 compared to net loss of $60.6 million for the same period in 2012. Fully diluted net income per share was $2.22 compared to net loss per share of $1.65 for the same period in 2012.

Cincinnati Financial Slips to Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 5:55PM CST
We are downgrading our recommendation on Cincinnati Financial to Neutral from Outperform, reflecting our concern regarding potential first-quarter earnings drain due to weather-related losses.

Greenlight Capital Re to Release Fourth Quarter and Year End 2013 Results
GlobeNewswire - Tue Feb 11, 3:01PM CST
Greenlight Capital Re, Ltd. (Nasdaq:GLRE), a specialist property and casualty reinsurer based in the Cayman Islands and Ireland, today announced that it expects to release financial results for the fourth quarter and year ended December 31, 2013 after the market closes on Tuesday, February 18, 2014. A live conference call to discuss the financial results will be held on Wednesday, February 19, 2014 at 9:00 a.m. Eastern time.

Markel's Earnings Miss, Revs Top Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 10:20AM CST
Markel reported fourth-quarter 2013 operating net income of $5.92 per share, missing the Zacks Consensus Estimate of $5.99 per share by 1.2%

Q4 Earnings at Allied World Miss Ests, Surge Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 10:40AM CST
Allied World reported fourth-quarter 2013 operating net income of $2.17 per share, missing the Zacks Consensus Estimate of $2.40 by 10.4%

Shares of GLRE Up 37.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 23, 4:56PM CST
SmarTrend identified an Uptrend for Greenlight Capital Re (NASDAQ:GLRE) on January 31st, 2013 at $23.96. In approximately 12 months, Greenlight Capital Re has returned 37.85% as of today's recent price of $33.03.

Greenlight Capital Re Has Returned 40.2% Since SmarTrend Recommendation (GLRE)
Comtex SmarTrend(R) - Thu Jan 16, 11:08AM CST
SmarTrend identified an Uptrend for Greenlight Capital Re (NASDAQ:GLRE) on January 31st, 2013 at $23.96. In approximately 12 months, Greenlight Capital Re has returned 40.23% as of today's recent price of $33.60.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...